Orsiro | 合法醫療器材資訊網

Verythinstrutbiodegradablepolymereverolimus-elutingstentsversusdurablepolymerzotarolimus-elutingstentsinall-comerswithcoronaryarterydisease ...

1 von Birgelen et al. Very thin strut biodegradable polymer everolimus-eluting stents versus durable polymer zotarolimus-eluting stents in all-comers with coronary artery disease (BIO-RESORT): a three-arm, randomised, non-inferiority trial. The Lancet 2016. 10.1016.S0140-6736(16)31920-1 and presentation at TCT 2016;

2 TLF as a composite of cardiac death, target vessel-related myocardial infarction, or clinically indicated target lesion revascularization;

3 Pilgrim et al. Ultrathin strut biodegradable polymer sirolimus-eluting stent versus durable polymer everolimus-eluting stent for percutaneous coronary revascularization (BIOSCIENCE): a randomised, single-blind, non-inferiority trial. The Lancet 2014.10.1016/S0140-6736(14)61038-2;

4 TLF as a composite of cardiac death, target vessel myocardial infarction, and clinically indicated target lesion revascularization; ...